57,48 47,50 excl. VAT

H361

Gangliosidosis (GM2, B variant, type 1) is a fatal, progressive neurodegenerative lysosomal storage disease caused by a deficiency of β-hexosaminidase.

10 working days

€5,95 shipping and administration per order (incl. VAT)

Specifications

Breeds

Gene

Organ

specimen

Swab, Blood EDTA, Blood Heparin, Semen, Tissue

Mode of Inheritance

Chromosome

Also known as

Year Published

General information

Gangliosidosis (GM2, B variant, type 1) is a fatal, progressive neurodegenerative lysosomal storage disease caused by a deficiency of β-hexosaminidase. The enzyme is composed of a dimer of two subunits α and β encoded by genes HEXA and HEXB. GM2 gangliosidosis can be caused by defects in the genes HEXA (Tays–Sachs disease, B-variant; where only the isoform A is deficient), HEXB (Sandhoff disease, O-variant; where both isoforms are involved). Mutations within the variants of β-hexosaminidase allow a build-up of toxic substances in the nerve cells (mainly neurons). An autosomal recessive mutation in HEXA is observed in the Japanese Chin dog (also known as Japanese Spaniël).

Clinical features

Dogs affected with Gangliosidosis type 1 can show a variety of symptoms including lack of coordination, depression, behavioral changes, head shaking, mental dullness, seizures, blindness, deafness, developmental delay. The disease is progressive and is likely to lead to death within several months. Euthanasia on humane grounds is likely to be considered.

Additional information

References

Pubmed ID: 23266199

Omia ID: 1461

How does it work?

1. Select your product(s)

Select your single test, a CombiBreed Package or create your own Bundle.

2. Collect DNA sample

Collect DNA material as indicated with our products and send it to our laboratory.

3. Results

We handle your DNA sample with care and provide you with the results.

Related products